Skip to main content
[Preprint]. 2023 Sep 13:2023.05.15.23289680. Originally published 2023 May 16. [Version 2] doi: 10.1101/2023.05.15.23289680

Figure 2:

Figure 2:

Cumulative incidence curves of (i) All-grade immune checkpoint inhibitor-mediated colitis (IMC) and (ii) Severe IMC by categories of polygenic risk score of ulcerative colitis (PRSUC) in the entire GeRI cohort. PRSUC is categorized as ≤10th percentile (low genetic risk), 10–90th percentile (average genetic risk), and >90th percentile (high genetic risk).